ORIGINAL RESEARCH
Accepted on 22 Apr 2025
Real-world treatment patterns and outcomes among patients initiating SEQuential Regorafenib and Trifluridine/Tipiracil+/-bevacizumab in patients with metastatic colorectal cancer in a US community setting (SEQRT2)
doi 10.3389/fonc.2025.1591245